首页 | 本学科首页   官方微博 | 高级检索  
     


Gonadotropin-releasing hormone (GnRF), Molluscan cardioexcitatory peptide (FMRFamide), enkephalin and related neuropeptides affect goldfish retinal ganglion cell activity
Authors:Steven E. Walker  William K. Stell  
Affiliation:1. Instituto de Ciencia Animal, Facultad de Ciencias Veterinarias, Universidad Austral de Chile, 5110566 - Valdivia, Chile;2. Centro Regional de Investigación Remehue, Instituto de Investigaciones Agropecuarias (INIA), Casilla 24-0 - Osorno, Chile;1. Istanbul University, Cerrahpasa Medical Faculty, Department of Medical Biology, Istanbul, Turkey;2. Bezmialem Vakif University, Medical Faculty, Department of General Surgery, Istanbul, Turkey;3. Bezmialem Vakıf University, Medical Faculty, Department of Medical Pathology, Istanbul, Turkey;4. Istanbul University, Capa Medical Faculty, Department of General Surgery, Istanbul, Turkey
Abstract:Recently gonadotropin-releasing hormone (GnRF)-like and molluscan cardioexcitatory peptide (FMRFamide)-like compounds have been colocalized immunocytochemically to the terminal nerve, a presumed olfactoretinal efferent system in goldfish. In the present study these and related neuropeptides were shown to affect ganglion cell activity, recorded extracellularly, when applied to the isolated superfused goldfish retina. GnRF was usually excitatory. Salmon GnRF (sGnRF) was 10-30x more potent than chicken or mammalian GnRF. FMRFamide and enkephalin also were often excitatory but caused more varied responses than sGnRF. Met5-enkephalin-Arg6-Phe7-NH2 (YGGFMRFamide), which contains both enkephalin and FMRFamide sequences, tended to act like both of these peptides but with mainly enkephalin-like properties. Neuropeptide Y and the C-terminal hexapeptide of pancreatic polypeptides, whose C-terminus (-Arg-Tyr-NH2) is closely related to that of FMRFamide (-Arg-Phe-NH2), gave no consistent responses. Threshold doses were equivalent to: 0.1 microM for sGnRF; 0.5 microM for YGGFMRFamide; 1.5 microM for FMRFamide and enkephalin. Rapid, complete and irreversible desensitization was induced by single, 10-20x threshold doses of sGnRF; but desensitization was infrequent and limited with the other peptides. In general, all peptides tested affected the spatially and chromatically antagonistic receptive field components similarly, but selective actions were seen in a few cases with FMRFamide and with the opioid antagonist, naloxone. Responses, especially to sGnRF and FMRFamide, tended to be most frequently obtained and pronounced in winter and spring, suggesting a correlation with seasonally regulated sexual and reproductive activity. Our observations provide further evidence for transmitter-like roles of neuropeptides related to sGnRF and FMRFamide in the teleostean terminal nerve. The actions of agonists and antagonists, singly and in combination, imply strongly that there are distinctive postsynaptic receptors and/or neural pathways for GnRF-, FMRFamide- and enkephalin-like peptides in the goldfish retina.
Keywords:Neuropeptide   Gonadotropin-releasing hormone (GnRF)   Enkephalin   Molluscan cardioexcitatory peptide (FMRFamide)   Retinal ganglion cell   Terminal nerve
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号